What is LOPJLB’s current signal on CALC?

LOPJLB’s latest quantitative signal on CalciMedica, Inc. (CALC) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is CALC in?

CalciMedica, Inc. (CALC) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does CalciMedica, Inc. (CALC) do?

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tis…

CalciMedica, Inc. (CALC)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$1.12-7.44%Close

SELLCRISIS · day 49

[SCORES & PROFILE]

FUND: 9
VALUE: 19
GROWTH: 39
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-108.9%

GROSS

NET

[VALUATION]

P/E TTM-0.16

P/E FWD-

SECTOR PE20.34

INDUSTRY PE13.84

P/B0.69

P/FCF-

EV/EBITDA0.76

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO5.58

ND/EBITDA-

BETA1.12

FAQ

What is LOPJLB’s current signal on CALC?: LOPJLB’s latest quantitative signal on CalciMedica, Inc. (CALC) is SELL in a CRISIS regime. Signals are updated daily.
What market regime is CALC in?: CalciMedica, Inc. (CALC) is currently classified in the CRISIS HMM market regime on LOPJLB.
What does CalciMedica, Inc. (CALC) do?: CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tis…

CalciMedica, Inc. (CALC)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ